Morgan Stanley Anika Therapeutics, Inc. Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 394,741 shares of ANIK stock, worth $3.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
394,741
Previous 108,382
264.21%
Holding current value
$3.92 Million
Previous $1.15 Million
223.73%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding ANIK
# of Institutions
118Shares Held
10.7MCall Options Held
0Put Options Held
0-
Trigran Investments, Inc.1.62MShares$16.1 Million2.92% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA781KShares$7.76 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA633KShares$6.29 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX601KShares$5.98 Million0.0% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $145M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...